ABSTRACT
BACKGROUND: Mastitis is one of the major diseases in dairy cattle, as it causes great economic losses to producers due to the reduction of milk production and changes in the quality of the product. The disease is mainly caused by bacteria of the genus Staphylococcus spp., these microorganisms can express various virulence factors, such as biofilms for example. In herds with organic management, producers and technicians use unconventional ways to treat and control the disease, such as homeopathy. However, it is not known if this type of treatment is able to control pathogenic bacteria such as those of the genus Staphylococcus, of relevance to animal and human health. Thus, the objective of this study was to investigate the production of biofilm in vitro and its genes by Staphylococcus spp. isolated in the milk of cows treated with homeopathy, as well as the persistence of microorganisms in animals. METHODS: Ninety-nine isolates of Staphylococcus spp. from cows treated and not treated with homeopathy were identified by internal transcribed space-polymerase chain reaction and investigated for the presence of the icaABCD, bap, aap, atlE, and bhp genes and in vitro biofilm production using the adhesion method on polystyrene plates. The enzyme restriction profile was determined by Pulsed-Field Gel Electrophoresis. Clusters of S. aureus and S. epidermidis with three or more isolates had an isolate selected for Multilocus Sequence Typing. RESULTS: The frequency of S. aureus isolations was similar in treated and untreated cows, while 71.4% of the coagulase-negative identified were isolated in cows treated with homeopathy. The distribution of the operon ica genes was similar in animals with and without treatment, except for the icaD gene, more frequent in treated cows. Production of biofilm was associated with presence of one or more genes from the icaADBC operon. S. aureus revealed a greater diversity and greater dissemination in cows treated and not treated with homeopathy. Sequence Types ST1, ST5, and ST126 were identified in S. aureus. CONCLUSIONS: The presence of biofilm-associated genes and the in vitro production of biofilms, combined with the persistence of clonal profiles of Staphylococcus spp. demonstrate other forms of control for bovine mastitis should be researched for organic production herds.
Subject(s)
Cattle Diseases , Homeopathy , Mastitis, Bovine , Staphylococcal Infections , Animals , Biofilms , Cattle , Female , Homeopathy/veterinary , Humans , Mastitis, Bovine/microbiology , Mastitis, Bovine/therapy , Milk/microbiology , Staphylococcal Infections/microbiology , Staphylococcal Infections/veterinary , Staphylococcus/genetics , Staphylococcus aureus/geneticsABSTRACT
INTRODUCTION: At present, the usage of antimicrobial agents in organic dairy farming is a subject of controversial public debate because of its impact on animals, humans and the environment. This study shows how farms can be successfully managed without using antimicrobials for udder diseases. Thereby, animal welfare and targeted low bulk tank somatic cell counts should not be neglected. The operating data analysed in this study was collected during feeding and milking time on 18 swiss dairy farms that have not been treating diseased udders with antibiotics for at least 3 years. This study is a cross-sectional study. Farmers put the focus on breed characteristics such as a high life performance, low bulk tank somatic cell counts over several lactations, animals with a calm character, and small-formed cows with a deep flank. A trend towards dual-purpose breeds was observed. Few persons were involved in the milking process. Moreover, 94% of the farmers were raising their own young cattle directly on the farm. Consequently, animal transport has been minimized. Furthermore, clear management practices and work processes as well as a good animal observation influenced decisively the production success. additionally some farmers used phytotherapy, homeopathy and tried and true home remedies.
INTRODUCTION: Dans l'élevage laitier, les médicaments vétérinaires contenant des antibiotiques susceptibles d'avoir un effet sur l'homme, l'animal et l'environnement sont un sujet discuté de façon controversée dans le grand public. La présente étude veut démontrer comment fonctionnent des exploitations qui n'utilisent pas de préparations antibiotiques intra-mammaires. Cela doit se passer sans que ni le bien-être des animaux ni un nombre de cellules bas dans le lait ne soient affectés. Les données utilisées pour ce travail ont été collectées pendant l'affouragement et la traite sur 18 exploitations suisses qui, dans les 3 années précédentes, n'avaient pas utilisé d'antibiotiques au niveau de la mamelle. Il s'agit ici d'une étude transversale qui présente les prévalences. Les producteurs s'intéressent à des caractéristiques d'élevage tels que la production totale sur la durée de vie de l'animal, un nombre de cellules bas au cours de plusieurs lactations, un caractère paisible et des vaches de petit format avec une flanc profond. On a constaté une tendance en direction des races à deux fins. Les propriétaires portaient leur attention à ce qu'un petit nombre de personnes pratiquent la traite régulièrement. Vu l'élevage des propres jeunes animaux sur 94% des exploitations, le trafic des animaux a été réduit. D'autre part, des structures d'exploitation et des processus de travail clairs ainsi qu'une bonne observation des animaux avaient un effet décisif sur le succès de ce mode de production. Sur ces exploitations, des méthodes de traitement spécifiques, telles l'homéopathie ou la phytothérapie ainsi que des remèdes traditionnels étaient utilisés en soutien.
Subject(s)
Animal Welfare , Anti-Bacterial Agents/administration & dosage , Cattle Diseases/therapy , Dairying/methods , Milk/metabolism , Animals , Cattle , Cattle Diseases/drug therapy , Cattle Diseases/metabolism , Conservative Treatment , Cross-Sectional Studies , Female , Mammary Glands, Animal/physiology , Prescription Drug Overuse/prevention & control , Quality of LifeABSTRACT
Mastitis is one of the most common diseases in dairy production, and homeopathic remedies have been used increasingly in recent years to treat it. Clinical trials evaluating homeopathy have often been criticized for their inadequate scientific approach. The objective of this triple-blind, randomized controlled trial was to assess the efficacy of homeopathic treatment in bovine clinical mastitis. The study was conducted on a conventionally managed dairy farm between June 2013 and May 2014. Dairy cows with acute mastitis were randomly allocated to homeopathy (n = 70) or placebo (n = 92), for a total of 162 animals. The homeopathic treatment was selected based on clinical symptoms but most commonly consisted of a combination of nosodes with Streptococcinum, Staphylococcinum, Pyrogenium, and Escherichia coli at a potency of 200c. Treatment was administered to cows in the homeopathy group at least once per day for an average of 5 d. The cows in the placebo group were treated similarly, using a placebo preparation instead (lactose globules without active ingredients). If necessary, we also used allopathic drugs (e.g., antibiotics, udder creams, and anti-inflammatory drugs) in both groups. We recorded data relating to the clinical signs of mastitis, treatment, time to recovery, milk yield, somatic cell count at first milk recording after mastitis, and culling. We observed cows for up to 200 d after clinical recovery. Base-level data did not differ between the homeopathy and placebo groups. Mastitis lasted for an average of 6 d in both groups. We observed no significant differences in time to recovery, somatic cell count, risk of clinical cure within 14 d after disease occurrence, mastitis recurrence risk, or culling risk. The results indicated no additional effect of homeopathic treatment compared with placebo. The advantages or disadvantages of homeopathy should be carefully assessed for individual farms.
Subject(s)
Homeopathy/veterinary , Mastitis, Bovine/therapy , Animals , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Cattle , Cell Count/veterinary , Female , Lactation , Mammary Glands, Animal , Milk/cytology , Milk/metabolism , Placebos/therapeutic use , Skin Cream/therapeutic use , Symptom Assessment/methods , Symptom Assessment/veterinary , Treatment OutcomeABSTRACT
Clinical mastitis is an important disease in dairies. Its treatment is mainly based on the use of antimicrobial drugs. Numerous non-antimicrobial drugs and treatment strategies have already been reported for clinical mastitis treatment, but data on their efficacy have never been collated in a systematic way. The objective of this systematic review was to identify treatments other than conventional antimicrobials for the treatment of clinical mastitis in lactating dairy cows. A systematic review was performed with studies written in English or French selected from CAB Abstracts, PubMed, and Web of Science from January 1970 to June 2014. Controlled clinical trials, observational studies, and experimental challenges were retained. Lactating dairy cows with clinical mastitis were the participant of interest. All treatments other than conventional antimicrobials for clinical mastitis during lactation were retained. Only studies comparing the treatment under investigation to a negative or positive control, or both, were included. Outcomes evaluated were clinical and bacteriological cure rates and milk production. Selection of the study, data extraction, and assessment of risk of bias was performed by 3 reviewers. Assessment of risk of bias was evaluated using the Cochrane Collaboration tool for systematic review of interventions. A total of 2,451 manuscripts were first identified and 39 manuscripts corresponding to 41 studies were included. Among these, 22 were clinical trials, 18 were experimental studies, and 1 was an observational study. The treatments evaluated were conventional anti-inflammatory drugs (n = 14), oxytocin with or without frequent milk out (n = 5), biologics (n = 9), homeopathy (n = 5), botanicals (n = 4), probiotics (n = 2), and other alternative products (n = 2). All trials had at least one unclear or high risk of bias. Most trials (n = 13) did not observe significant differences in clinical or bacteriological cure rates in comparison with negative or positive controls. Few studies evaluated the effect of treatment on milk yield. In general, the power of the different studies was very low, thus precluding conclusions on noninferiority or nonsuperiority of the treatments investigated. No evidence-based recommendations could be given for the use of an alternative or non-antimicrobial conventional treatment for clinical mastitis. However, probiotics and oxytocin with or without frequent milk out should not be recommended. We concluded that homeopathic treatments are not efficient for management of clinical mastitis.
Subject(s)
Mastitis, Bovine/therapy , Animals , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Biological Products/therapeutic use , Cattle , Female , Homeopathy , Lactation , Milk/metabolism , Oxytocin/therapeutic use , Phytotherapy , Probiotics/therapeutic useABSTRACT
The aims of this study were to investigate the environmental, feeding, and health management of organic (ORG) family dairy farms in the south of Brazil in comparison with conventional (CONV) farms, and to assess their degree of compliance with Brazilian organic legislation and the strategies they adopt to accomplish this (n=17 per group). During 2 visits to each farm in March and September, 2010, observations were made on the environment, feed, and health management, followed by bulk milk testing, clinical evaluation, and breed assessment of each individual cow, and an evaluation of diseases and treatments reported within the period. Additional data were collected directly from the farmers through direct interviews. The number of lactating cows was, on average, 11 (range 5 to 19) in the ORG and 16 (range 7 to 42) in the CONV herds. The ORG herds presented a lower percentage of the Holstein breed; whereas CONV herds were predominantly Holstein, in the ORG herds, only 2 herds were 100% Holstein and the remaining herds were crosses of Holstein, Jersey, and Gir (Bos indicus) cattle. Milk production per cow was lower (10.2 vs. 15.1 ± 1.22 L/cow, respectively) in ORG than in the CONV farms. The ORG farms offered less concentrate feed than CONV farms and had better pasture management. Organic farmers reported using phytotherapic and homeopathic products, and pasture management as a strategy to keep infection levels of endo- and ectoparasites low, whereas CONV farmers regularly used anthelmintics and acaricides. Milk production was lower in ORG than in CONV farms, but cow health and condition scores were broadly similar, indicating that the with these strategies ORG farms were able to secure levels of animal welfare comparable with CONV farms while complying with organic regulation, although at the cost of lower cow productivity.
Subject(s)
Dairying/methods , Dairying/standards , Organic Agriculture/methods , Organic Agriculture/standards , Animal Feed/standards , Animal Welfare , Animals , Brazil , Cattle , Diet/standards , Diet/veterinary , Female , Food Quality , Genotype , Government Regulation , Lactation , MilkABSTRACT
The present study examines the efficacy of a homeopathic dry cow prophylaxis in a randomized, placebo controlled case-control field trial. The study was conducted in 24 Brown Swiss farms in the Engadine (Swiss mountain region). The effect of the used homeopathic substances were combined with antibiotics in justified cases. At drying off and in the 3rd and 5th week of lactation the udders were clinically examined and quarter milk samples were taken for bacteriological and cytological analysis. In addition, milk recording data of the first 6 milk testing were included in the evaluations. The used homeopathic prophylaxis at drying off did not show any effect in the incidence of dry cow mastitis and mastitis in the first 120 days of lactation. However, at day 21 post partum significantly fewer animals in the verum group showed a bacteriological finding of a major pathogen, but more animals in this group suffered from a secretion disorder. It has been shown that at the 6th milk test pp significantly more animals of the verum group had a somatic cell count below 100'000 cells/ml than the control group.
Dans cette étude, on contrôle l'efficacité d'une prévention homéopathique lors du tarissement dans le cadre d'une étude randomisée versus placebo. L'étude a été réalisée dans 24 exploitations en Engadine, élevant de la race brune. L'efficacité des produits homéopathiques utilisés a également été considérée en tenant compte des antibiotiques appliquées dans les cas fondés. Chez tous les animaux on a recueilli un échantillon de chaque quartier lors du tarissement ainsi qu'en 3ème et 5ème semaine de lactation. Ces échantillons ont été examinés du point de vu bactériologique et quant au nombre de cellules. En outre, le taux de cellules des 6 premiers contrôles laitier a été intégré dans le calcul des résultats. La prévention homéopathique lors des tarissement n'a pas montré d'effet quant à l'apparition de mammites durant la période de tarissement ou durant les 120 premiers jours de la lactation. On a toutefois pu montrer que, 21 jours postpartum, le nombre d'animaux présentant des résultats bactériologiques avec des germes importants pour les mammites était significativement plus bas mais qu'un plus grand nombres d'animaux souffraient des troubles de la sécrétion. Lors du 6ème contrôle laitier postpartum, il y avait dans le groupe test plus d'animaux avec un taux de cellule inférieur à 100'000/ml que dans le groupe de contrôle.
Subject(s)
Mastitis, Bovine/prevention & control , Materia Medica/therapeutic use , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Cattle , Cell Count/veterinary , Female , Incidence , Lactation , Mammary Glands, Animal/microbiology , Mammary Glands, Animal/pathology , Mastitis, Bovine/epidemiology , Materia Medica/administration & dosage , Milk/cytology , Milk/microbiology , Postpartum Period , Switzerland/epidemiologyABSTRACT
Background: Mastitis is a disease of productive cows, widespread throughout the world, and characterized by significant economic damage to the dairy industry. The subclinical form of this disease is aggravated by additional difficulties with its diagnosis and the lack of clear treatment protocols. Aim: Therefore, the study of the effectiveness of diagnostic studies and the search for new methods of treatment of latent forms of mastitis is an important direction in scientific research in countries with developed dairy cattle breeding. Methods: Studies conducted on the number of dairy cows of the production cooperative "Izhevsky" of the Akmola region of the Republic of Kazakhstan showed that when using rapid tests Kenotest, Somatest, Mastidine test, and Wideside test, the same results were obtained when the disease was detected in cows. The effectiveness of the tests was at the level of 60%-62% when using the settling sample as a control. Medical procedures were carried out using the Aquaton-2 microwave radiation apparatus and a homeopathic preparation. When using physiotherapy with microwave radiation, a decrease in the level of microbial contamination of milk from the treated part of the udder by 1.5-5 times was observed. Results: Biologically active substances of plant origin in the homeopathic preparation, due to the immunostimulating effect, made it possible to increase the level of γ-globulins in the blood serum of sick animals during the application. Conclusion: The complex use of both methods in the treatment of animals with a subclinical form of mastitis made it possible to reduce the level of somatic cells in the milk of the affected udder lobe to a level that cannot be determined using Kenotest in 4-6 days, which is 2-4 days faster than using these methods separately.
Subject(s)
Cattle Diseases , Mastitis , Female , Cattle , Animals , Mastitis/veterinary , Kazakhstan , Mammary Glands, Animal , MilkABSTRACT
Background: The increase in the intensity of livestock industries, by improving the technology of animal product manufacturing, largely depends on the correct organization of herd reproduction and the intensity of using the biological capabilities of the animal organism. Various diseases, including such common diseases as mastitis, complicate the successful reproduction and growth of enterprise productivity. The widespread use of antibiotic-containing drugs for the treatment of mastitis creates a number of inevitable consequences for the body. The relevance of the study is due to the fact that the residual content of antibiotics in the collected milk after the course of treatment poses a serious danger to human health and reduces the quality of dairy products obtained from such milk. Aim: The authors set the task of developing a new, antibiotic-free method of treating bovine mastitis. This paper is devoted to the problem of improving methods of treating the subclinical mastitis in dairy cattle by alternative methods during the interlactation period. Methods: The leading method for the study of this problem is an experimental method that allows to develop and test a veterinary homeopathic substance for the treatment of subclinical mastitis in cows during the interlactation period. Results: This paper presents materials on the typification of microflora in the milk of cows with subclinical mastitis and the effectiveness of a veterinary homeopathic substance developed by the authors. The use of the veterinary homeopathic substance provided a high therapeutic effect, and did not cause side effects and complications in cows. Conclusion: The resulting veterinary substance was tested and introduced into the "Izhevskiy" natural complex of Akmola region as a new alternative method of treating subclinical mastitis in cows. Based on this substance, a drug for the treatment of mastitis will be developed and proposed for production.
Subject(s)
Cattle Diseases , Mastitis, Bovine , Humans , Cattle , Animals , Female , Mastitis, Bovine/drug therapy , Milk , Anti-Bacterial Agents/therapeutic useABSTRACT
Despite the recent growth of the organic dairy industry, organic producers and veterinarians have limited information when choosing mastitis treatments for animals in organic dairy production. Organic producers commonly administer homeopathic or other plant-based products without having research evaluating the efficacy of these products and using estimated or no withholding times to treat mastitis and other health problems in their herds. In this pilot study, we attempted to identify several active ingredients of Phyto-Mast (Penn Dutch Cow Care, Narvon, PA), a plant-based mastitis treatment used on organic dairy farms, and to quantify the product residue in milk and plasma after intramammary administration. We developed an assay to quantify thymol (one of the active ingredients in Phyto-Mast) in milk and plasma using gas chromatography and mass spectrometry (GC-MS). Thymol is a volatile aromatic compound with antiinflammatory properties. As a model for dairy cows, 5 healthy, lactating alpine dairy goats were given 5 mL of Phyto-Mast per udder half. For 10 d following treatment, we analyzed blood and milk samples for thymol residues using GC-MS. The GC-MS assay was very sensitive for thymol detection, to a concentration of 0.01 µg/mL in plasma. Using thymol as a marker, Phyto-Mast was detectable and quantifiable in plasma beginning with the 15-min posttreatment sample, but was no longer detectable in the 4-h posttreatment sample. Thymol residues were only detected in the 12-h posttreatment milk sample. An inflammatory response was not evident in the udder following phytoceutical administration. Although this study provides information about the elimination of thymol, the product contains several other active chemicals, which may have different pharmacokinetic behaviors. Further analysis and additional study animals will help to determine a milk withholding time for Phyto-Mast. Given the recent growth of the organic dairy industry, understanding the pharmacokinetics of therapeutics used in organic production and developing accurate withholding recommendations will help to ensure milk safety.
Subject(s)
Anti-Infective Agents, Local/analysis , Drug Residues/analysis , Mammary Glands, Animal/metabolism , Mastitis/veterinary , Milk/chemistry , Phytotherapy/veterinary , Thymol/analysis , Angelica sinensis , Animals , Anti-Infective Agents, Local/blood , Anti-Infective Agents, Local/therapeutic use , Dairying/methods , Drug Administration Routes , Female , Gaultheria , Glycyrrhiza uralensis , Goats , Mastitis/drug therapy , Mastitis/metabolism , Pilot Projects , Thymol/blood , Thymol/therapeutic use , Thymus PlantABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: Dynameron is a Byzantine medical compendium, divided into 24 sections, in accordance with the letters of the Greek alphabet. Being the largest medical and pharmaceutical book ever written in Byzantium, Dynameron contains 2667 recipes intended to treat many pathological conditions. A lot of information convey to us through prescriptions. In addition to plants, Nikolaos Myrepsos proposes the use of many animals, animal parts and animal by-products, for the treatment of various diseases. This article presents for the first time a full account of the animal products included in Dynameron. AIM OF THE STUDY: In continuation to our previous studies, this paper focuses on the use of animal products in composite medicines described in Dynameron. An effort was made to trace down the use of similar or identical animal products in texts of earlier medical writers. Recording recipes with animals or animal products intended for use in everyday medical practice highlights the timeless belief in their healing properties. MATERIALS AND METHODS: Our main source of material is the recent digital edition of Nikolaos Myrepsos' Dynameron. This huge treatise was written in the 13th century and reflects in many ways the long medical tradition of the Greek, the Hellenistic and the Roman eras, having also received influences from the materia medica of Arabic medicine. In addition, information from dictionaries and databases were cross-checked to confirm and classify the animals and their products and to identify them. For the various pathological conditions these products are meant for, we have used the current medical terminology. RESULTS: In the present study, we could identify the therapeutic use of 93 animals. In several instances, Myrepsos suggests the use of specific organs of an animal, and for that reason he includes in his treatise 16 anatomical parts of different animals. Moreover, Dynameron comprises also 34 animal by-products, such as milk and honey. Medicines of animal origin are used in recipes concerning diseases of the respiratory, the digestive, the cardiovascular and the urinary system, as well as gynecological diseases, and ailments of the eyes, the ears and the skin. CONCLUSIONS: Of the 2667 recipes of Dynameron, 344 recipes contain medicines of animal origin, which can be detected in totally 769 citations. In addition, 626 citations for animal by-products are found in 268 recipes. Honey and milk are quoted in 2136 recipes, mostly as excipients. Dietary instructions are present on many occasions, reflecting the attitude for a healthy everyday life, similar to the modern beliefs pertaining to food as an essential factor for a good health.
Subject(s)
Biological Products/therapeutic use , Tissue Extracts/therapeutic use , Animals , Byzantium , Databases, Factual , Honey , Humans , Materia Medica , Medicine, Traditional , MilkABSTRACT
INTRODUCTION: Routine use of antibiotics to prevent mastitis in dairy cows is prohibited by organic farming regulations. Internal Teat Sealers have been proposed as an alternative. We compared two drying-off (DO) supporting measures (Internal Teat Sealer and Homeopathy) to an untreated control group to assess their protective effects against clinical mastitis and intra-mammary infections during dry period of dairy cows. METHODS: A field trial with 102 dairy cows from 13 Swiss organic dairy farms was conducted. Cows were randomly assigned to one of three groups within a herd. In the Internal Teat Sealer group (ITS; 36 cows) cows were treated with the commercial ORBESEAL (Pfizer) in all four quarters immediately after the last milking. In the Homeopathy group (HDT; 32 cows) the cows were treated per-orally by a herd-specific homeopathic formulation consisting of two remedies in 1:10(6) dilution over 5 days before and after DO. The untreated group received no therapy (U; 34 cows). RESULTS: For ITS, HDT and U the clinical mastitis incidence rates for the first 100 days post-calving were 11%, 9% and 3%, respectively, and the proportion of normally secreting quarters was (quarter somatic cell count (SCC) [QSCC]<100,000/ml) 70%, 68%, and 65%, respectively. Power analysis indicates that a proportion of 75% would support the rejection of null hypothesis in the HDT, and 74% in the ITS group against untreated control. Quarters of cows with SCC<200,000/ml at DO showed significantly higher normal secretion in HDT group (odds ratio [OR] 9.69) compared to untreated control, whereas Teat Sealing lead to an OR of 3.09 (not significant, post hoc power 31.3%). CONCLUSIONS: Under the studied conditions herd-specific homeopathic dry cow therapy was effective in increasing the number of animals with normal milk secretion after subsequent parturition, compared to untreated control. It may be an effective alternative to Teat Sealing, particularly in animals with relatively low SCCs. Further research is required to confirm these results, and under different environmental conditions.
Subject(s)
Homeopathy , Mastitis, Bovine/prevention & control , Animals , Anti-Bacterial Agents/therapeutic use , Cattle , Dairying , Female , Lactation , Logistic Models , Mammary Glands, Animal , Mastitis, Bovine/microbiology , Milk/metabolism , Random AllocationABSTRACT
BACKGROUND: The purpose of the present study was to develop intranasal delivery systems of the homeopathic anti-asthmatic remedy Blatta orientalis mother tincture (Q) using thermoreversible polymer Pluronic F127 (PF127) and mucoadhesive polymer Carbopol 934P (C934P). METHODS: Formulations were modulated so as to have a gelation temperature below 34 degrees C to ensure gelation at physiological temperature after intranasal administration. Its gelation temperature, mucoadhesive strength, viscosity and gel strength were studied. B. orientalis (Q) nasal gel was tested with recurrent milk aspiration to determine whether it produces changes in eosinophilia in a murine model of asthma. RESULT: The gelation temperatures of the formulations and mucoadhesive strength, determined using sheep nasal mucosal membrane, increased by the addition of increasing concentrations of Carbopol. The results of milk aspiration induced eosinophilia, B. orientalis (Q) nasal gel significantly (P < 0.001), decreased eosinophil cell count as compared with toxicant by using in absolute eosinophilia count method. Finally, histopathological examination did not detect any damage during in vivo studies. CONCLUSION: The PF127 gel formulation of B. orientalis (Q) with in situ gelling and mucoadhesive properties with increased permeation rate is promising for prolonging nasal residence time and thereby nasal absorption.
Subject(s)
Cockroaches/chemistry , Excipients/chemistry , Pulmonary Eosinophilia/drug therapy , Respiratory Aspiration/complications , Acrylates/chemistry , Adhesiveness , Administration, Intranasal , Animals , Asthma/drug therapy , Asthma/physiopathology , Disease Models, Animal , Drug Delivery Systems , Female , Gels , Guinea Pigs , Homeopathy , Male , Mice , Milk , Nasal Mucosa/metabolism , Permeability , Poloxamer/chemistry , Pulmonary Eosinophilia/etiology , Rats , Rats, Wistar , Sheep , Temperature , ViscosityABSTRACT
The objective of the study was to assess the efficacy of different prophylactically applied homeopathic compounds on health and fertility during the periparturient period on an organic dairy farm. In a randomised double blinded study 146 dairy cows were enrolled in two treatment groups. The average milk yield was about 5100 kg per cow per lactation. The treatment group received the homeopathic compounds Carduus comp. and Coenzyme comp. at drying off, Traumeel on the day of calving, Lachesis comp. on day 7 post partum (p.p.) and Carduus comp. and Coenzyme comp. on day 14 days p.p. The control group followed the same protocol with a placebo (physiological saline solution). Each drug was administered subcutaneously in a dosage of 5 ml. At drying off, the day of calving and in weekly intervals until day 35 p.p. clinical examinations as well as blood sampling were performed. The effect of treatment was measured by clinical parameters, reproductive performance and serum profiles (Ca, P, AST, Urea, Bilirubin). Data of reproductive performance (days to first service, days open, conception rate) were compared between treatment groups and to those in the previous lactation. There was no significant difference between both treatment groups. Cows of the treatment group had an earlier onset of cyclic activity, especially when milk yield was considered as an influencing factor (82% vs. 57%, P < 0,05). In contrast the cows of the treatment group had a significant lower submission rate. The prophylactic treatment of all cows did not have an effect in general, but in cows with increased milk yield, especially in the current lactation. The reproductive performance in the previous lactation did not have any effects on the success of the homeopathic treatment. Reproductive performance in the herd could be enhanced slightly compared to the previous lactation.
Subject(s)
Fertility/drug effects , Formularies, Homeopathic as Topic , Lactation/physiology , Milk/metabolism , Animals , Cattle , Dairying/methods , Double-Blind Method , Female , Pregnancy , ReproductionABSTRACT
A study was undertaken to attempt to relate the distribution of exogenous factors to the varying incidences of esophageal cancer in the Caspian Littoral of Iran. For the study, 38 villages were chosen by random sampling in 14 regions defined by their esophageal cancer incidence and environmental characteristics. Information was obtained on the dietary, social, and cultural features of each village. In addition, an extensive 5-day study of 6 randomly selected households in each of the 38 villages was conducted. The study consisted of measured dietary intake, a historical food consumption questionnaire, and clinical examinations of adult occupants. Preliminary results show no single factor responsible for the etiology of esophageal cancer. However, there were some major dietary differences between the regions of different esophageal cancer risk. Bread was the chief staple food in high-incidence areas; rice, in low-incidence areas. In high-incidence areas, there was a low intake of vitamins A and C, riboflavin, animal protein, and fresh vegetables and fruit, but a greater consumption of sheeps and goat's milk. Analyses of food samples for aflatoxins, polycylic aromatic hydrocarbons, and nitrosamines showed low levels of these carcinogens in areas of high and low incidences. The use of tobacco and alcohol was not found to be of significance.
Subject(s)
Diet , Esophageal Neoplasms/etiology , Alcohol Drinking , Animals , Diet Fads , Dietary Proteins , Esophageal Neoplasms/epidemiology , Female , Humans , Iran , Male , Milk , Opium , Plants , Sampling Studies , Smoking , Tea , VitaminsABSTRACT
Cows in a 250-cow Holstein-Friesian herd were allocated at random to be treated with either a homoeopathic nosode or a negative control, both treatments being applied by means of an aerosol spray to the vulval mucous membranes. A total of six treatments were given over a period of three days and milk samples were taken for the determination of somatic cell counts (SCC) on days -3, 3, 7, 9, 14, 21 and 28. Individuals applying the treatments or carrying out the SCC determination were unaware of which animals were receiving which treatment. Owing to the wide natural variations in SCC, the trial had only a 71 per cent possibility of detecting a 30 per cent difference in SCC between the two groups. There were no significant differences between the SCC of the two groups on any sample day, but there were significant variations between the SCC on different days (P=0.003) in both groups.
Subject(s)
Mastitis, Bovine/drug therapy , Materia Medica/pharmacology , Milk/drug effects , Animals , Cattle , Cell Count/veterinary , Dairying , Female , Homeopathy , Mastitis, Bovine/pathology , Materia Medica/therapeutic use , Milk/cytology , Treatment OutcomeABSTRACT
A dataset of test-day records, fertility traits, and one health trait including 1275 Brown Swiss cows kept in 46 small-scale organic farms was used to infer relationships among these traits based on recursive Gaussian-threshold models. Test-day records included milk yield (MY), protein percentage (PROT-%), fat percentage (FAT-%), somatic cell score (SCS), the ratio of FAT-% to PROT-% (FPR), lactose percentage (LAC-%), and milk urea nitrogen (MUN). Female fertility traits were defined as the interval from calving to first insemination (CTFS) and success of a first insemination (SFI), and the health trait was clinical mastitis (CM). First, a tri-trait model was used which postulated the recursive effect of a test-day observation in the early period of lactation on liability to CM (LCM), and further the recursive effect of LCM on the following test-day observation. For CM and female fertility traits, a bi-trait recursive Gaussian-threshold model was employed to estimate the effects from CM to CTFS and from CM on SFI. The recursive effects from CTFS and SFI onto CM were not relevant, because CM was recorded prior to the measurements for CTFS and SFI. Results show that the posterior heritability for LCM was 0.05, and for all other traits, heritability estimates were in reasonable ranges, each with a small posterior SD. Lowest heritability estimates were obtained for female reproduction traits, i.e. h(2)=0.02 for SFI, and h(2)≈0 for CTFS. Posterior estimates of genetic correlations between LCM and production traits (MY and MUN), and between LCM and somatic cell score (SCS), were large and positive (0.56-0.68). Results confirm the genetic antagonism between MY and LCM, and the suitability of SCS as an indicator trait for CM. Structural equation coefficients describe the impact of one trait on a second trait on the phenotypic pathway. Higher values for FAT-% and FPR were associated with a higher LCM. The rate of change in FAT-% and in FPR in the ongoing lactation with respect to the previous LCM was close to zero. Estimated recursive effects between SCS and CM were positive, implying strong phenotypic impacts between both traits. Structural equation coefficients explained a detrimental impact of CM on female fertility traits CTFS and SFI. The cow-specific CM treatment had no significant impact on performance traits in the ongoing lactation. For most treatments, beta-lactam-antibiotics were used, but test-day SCS and production traits after the beta-lactam-treatment were comparable to those after other antibiotic as well as homeopathic treatments.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Cattle/physiology , Fertility , Mastitis, Bovine/genetics , Milk/metabolism , Animals , Cattle/genetics , Cattle/growth & development , Female , Lactation , Mastitis, Bovine/drug therapy , Mastitis, Bovine/epidemiology , Models, Genetic , Normal Distribution , Phenotype , Quantitative Trait, Heritable , Risk Factors , Switzerland/epidemiologyABSTRACT
Avaliou-se a influência do número de parições nos valores de alguns parâmetros bioquímicos e do perfil eletroforético do soro lácteo de vacas de corte. Trinta e cinco vacas da raça Canchim foram alocadas em cinco grupos: vacas de primeira lactação, segunda lactação, terceira e quarta lactações, quinta lactação e sexta lactação. As amostras de secreção láctea foram coletadas imediatamente após (dia 0) e 1, 2, 7, 15 e 30 dias após o parto. As concentrações de gamaglutamiltranferase (GGT), proteína total, cálcio, fósforo, magnésio e cálcio ionizado foram avaliadas. A separação eletroforética das proteínas foi realizada em matriz de gel de poliacrilamida (SDS-PAGE). A atividade de GGT e as concentrações de imunoglobulina G, cálcio e fósforo não foram influenciadas pelo número de parições. As concentrações de proteína total, cálcio ionizado, magnésio imunoglobulina A, lactoferrina, β - lactoglobulina e α - lactoalbumina, foram influenciadas pelo número de partos das vacas. À exceção dos teores de fósforo e α - lactoalbumina em poucos grupos, a concentração d a s demais características decresceu no decorrer do período de lactação.
Subject(s)
Animals , Biochemistry , Enzymes/analysis , Milk/classification , Minerals/analysis , Proteins/analysis , Cattle/classificationABSTRACT
This paper compares management of mastitis on organic dairy farms with that on conventional dairy farms. National standards for organic production vary by country. In the United States, usage of antimicrobials to treat dairy cattle results in permanent loss of organic status of the animal, effectively limiting treatment choices for animals experiencing bacterial diseases. There are no products approved by the US Food and Drug Administration that can be used for treatment of mastitis on organic dairy farms, and usage of unapproved products is contrary to Food and Drug Administration guidelines. In general, organic dairy farms tend to be smaller, produce less, and more likely to be housed and milked in traditional barns as compared with conventionally managed herds. It is difficult to compare disease rates between herds managed conventionally or organically because perception and detection of disease is influenced by management system. To date, no studies have been published with the defined objective of comparing animal health on organic dairy herds with that on conventional dairy herds in the United States. European studies have not documented significant differences in animal health based on adoption of organic management. Few differences in bulk tank somatic cell counts have been identified between organic and conventional herds. Farmers that have adopted organic management consistently report fewer cases of clinical mastitis, but organic farmers do not use the same criteria to detect clinical mastitis. European dairy farmers that adopt organic management report use of a variety of conventional and alternative therapies for treatment and control of mastitis. In the United States, organic farmers treat clinical mastitis using a variety of alternative therapies including whey-based products, botanicals, vitamin supplements, and homeopathy. Organic farmers in the United States use a variety of alternative products to treat cows at dry-off. Virtually no data are available that support the clinical efficacy of any of the alternative veterinary products used for treatment or prevention of mastitis. Some associations between organic management and antimicrobial susceptibility of gram-positive mastitis pathogens have been noted, but overall, few mastitis pathogens from both conventional and organic dairy herds demonstrate resistance to antibiotics commonly used for mastitis control.
Subject(s)
Bacterial Infections/veterinary , Dairying/methods , Food, Organic/standards , Mastitis, Bovine/therapy , Animals , Anti-Infective Agents/therapeutic use , Bacterial Infections/diagnosis , Bacterial Infections/economics , Bacterial Infections/microbiology , Bacterial Infections/therapy , Cattle , Complementary Therapies/veterinary , Dairying/economics , Dairying/standards , Disease Management , Female , Mastitis, Bovine/diagnosis , Mastitis, Bovine/economics , Mastitis, Bovine/microbiology , Milk/standardsABSTRACT
BACKGROUND: Mastitis is one of the major threats to animal health, in organic farming as well as conventional. Preliminary studies of organic dairy herds have indicated better udder health in such herds, as compared to conventional herds. The aim of this paper was to further study mastitis and management related factors in certified organic dairy herds. METHODS: An observational study of 26 certified organic dairy herds in mid-eastern Sweden was conducted during one year. A large-animal practitioner visited the herds three times and clinically examined and sampled cows, and collected information about general health and management routines. Data on milk production and disorders treated by a veterinarian in the 26 herds, as well as in 1102 conventional herds, were retrieved from official records. Multivariable logistic regression was used to assess associations between herd type (organic vs. conventional) and incidence of disorders. RESULTS: The organic herds that took part in the study ranged in size from 12 to 64 cows, in milk production from 3772 to 10,334 kg per cow and year, and in bulk milk somatic cell counts from 83,000 to 280,000 cells/ml. The organic herds were found to have a lower incidence of clinical mastitis, teat injuries, and a lower proportion of cows with a high somatic cell count (as indicated by the UDS, Udder Disease Score) compared to conventional herds. The spectrum of udder pathogenic bacteria was similar to that found in other Swedish studies. Treatment of mastitis was found to be similar to what is practised in conventional herds. Homeopathic remedies were not widely used in the treatment of clinical mastitis.The calves in most of these organic herds suckled their dams for only a few days, which were not considered to substantially affect the udder health. The main management factor that was different from conventional herds was the feeding strategy, where organic herds used a larger share of forage. CONCLUSION: Udder health in Swedish organic herds appears to be better than in conventional herds of comparable size and production. The major difference in management between the two types of farms is the proportion of concentrates fed. The mechanisms explaining the association between intensity of feeding and udder health in dairy cows require further research.
Subject(s)
Dairying/methods , Mastitis, Bovine/therapy , Animal Feed/analysis , Animals , Animals, Suckling , Bacteria/isolation & purification , Cattle , Disease Management , Female , Housing, Animal , Incidence , Mastitis, Bovine/epidemiology , Mastitis, Bovine/microbiology , Milk/cytology , Surveys and Questionnaires , Sweden/epidemiologyABSTRACT
We report an uncontrolled observational study of the treatment of udder diseases of buffalo, using a homeopathic complex medicine. Mastitis is an economically important disease of buffaloes. In India economic losses due to mastitis are estimated at 526 million US dollars annually. Conventional veterinary treatment relies on costly antibiotics; cure rate is only 60% in field conditions with a problem of milk residues. The present investigation was undertaken to evaluate the effectiveness of a homeopathic complex in the management of clinical udder health problems of riverine buffaloes. Cases of subclinical mastitis were excluded from the study. A total of 102 mastitic quarters (fibrosed--40, nonfibrosed--62) and five cases each of blood in milk and udder oedema in lactating buffaloes were treated with a homeopathic complex consisting of Phytolacca 200c, Calcarea fluorica 200c, Silicea 30c, Belladona 30c, Bryonia 30c, Arnica 30c, Conium 30c and Ipecacuanha 30c. The diagnosis of udder diseases and recovery criterion was based on physical examination of udder and milk and CMT/WST score. Bacteriological analysis and somatic cell count were not performed. Treatment was 80 and 96.72% effective in cases of fibrotic mastitis and nonfibrosed mastitis respectively. Recovery period was 21-42 days (fibrosed) and 4-15 days (nonfibrosed). Udder oedema and blood in milk responded favourably in 2-5 days. Cost of treatment was 0.07 US dollars per day. The homeopathic complex medicine may be effective and economical in the management of udder health problems of buffaloes. Definitive conclusions are premature due to the limited number of observations and lack of control group.